Flomerics Group PLC
09 September 2005
FOR IMMEDIATE RELEASE 09 September 2005
FLOMERICS GROUP PLC
Board Appointment
The Board of Flomerics Group PLC is pleased to announce that Gary Carter, who
joined the company in January 2005 as Chief Operating Officer, has been
appointed as Chief Executive Officer with immediate effect. This is the
culmination of the previously announced intention to ensure a smooth transition
of the management of the Company.
David Tatchell the co-founder of the company and Chief Executive since 1989 will
move into the role of Chief Technology Officer enabling the Company to continue
to benefit from his invaluable depth of knowledge of the Company's products and
underlying technology.
Flomerics Group recently announced Interim results for the six months ended 30
June 2005. Turnover for the six months ended 30 June 2005 was up 19% at £5.3
million (2004 : £4.4 million) (excluding contribution from the MicReD
acquisition, turnover up 13% at £5.0 million) and a record profit (before tax
and amortisation of goodwill) for the half year of £380,000 (2004 : £65,000
loss).
For further information, please contact :
Flomerics 020 8487 3000
David Mann, Non-executive Chairman
Chris Ogle, Finance Director
Buchanan Communications 020 7466 5000
Nicola Cronk / Frances Adigwe
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.